Operating Expenses Summary of ArcticZymes Technologies ASA

ArcticZymes Technologies ASA's latest annual operating expenses in 2023 was 97.26 Million NOK , down -75.03% from previous year.
ArcticZymes Technologies ASA's latest quarterly operating expenses in 2024 Q1 was 8.4 Million NOK , down -5.12% from previous quarter.
ArcticZymes Technologies ASA reported a annual operating expenses of 95.31 Million NOK in annual operating expenses 2022, up 45.18% from previous year.
ArcticZymes Technologies ASA reported a annual operating expenses of 65.65 Million NOK in annual operating expenses 2021, up 32.57% from previous year.
ArcticZymes Technologies ASA reported a quarterly operating expenses of 8.96 Million NOK for 2024 Q2, up 6.67% from previous quarter.
ArcticZymes Technologies ASA reported a quarterly operating expenses of 22.17 Million NOK for 2023 Q2, down -10.24% from previous quarter.

Annual Operating Expenses Chart of ArcticZymes Technologies ASA (2023 - 2002)

Historical Annual Operating Expenses of ArcticZymes Technologies ASA (2023 - 2002)

Year	Operating Expenses	Operating Expenses Growth
2023	97.26 Million NOK	-75.03%
2022	95.31 Million NOK	45.18%
2021	65.65 Million NOK	32.57%
2020	49.52 Million NOK	-22.74%
2019	64.1 Million NOK	4.11%
2018	61.57 Million NOK	-11.63%
2017	69.67 Million NOK	6.55%
2016	65.39 Million NOK	17.69%
2015	55.56 Million NOK	19.71%
2014	46.41 Million NOK	6.03%
2013	43.77 Million NOK	-0.96%
2012	44.2 Million NOK	4.37%
2011	42.34 Million NOK	-20.84%
2010	53.5 Million NOK	-50.23%
2009	107.49 Million NOK	-22.19%
2008	138.15 Million NOK	0.0%
2007	- NOK	-100.0%
2006	58.09 Million NOK	0.0%
2005	- NOK	-100.0%
2004	134.04 Million NOK	0.0%
2003	- NOK	0.0%
2002	- NOK	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	8.4 Million NOK	-5.12%
2024 Q2	8.96 Million NOK	6.67%
2023 Q2	22.17 Million NOK	-10.24%
2023 Q1	24.7 Million NOK	-7.31%
2023 Q4	8.85 Million NOK	-63.81%
2023 FY	23.79 Million NOK	-75.03%
2023 Q3	24.48 Million NOK	10.38%
2022 Q1	20.68 Million NOK	27.98%
2022 Q2	20.75 Million NOK	0.33%
2022 FY	95.31 Million NOK	45.18%
2022 Q3	27.21 Million NOK	31.14%
2022 Q4	26.65 Million NOK	-2.07%
2021 Q3	16.81 Million NOK	-3.28%
2021 Q2	17.38 Million NOK	13.79%
2021 FY	65.65 Million NOK	32.57%
2021 Q1	15.28 Million NOK	424.4%
2021 Q4	16.16 Million NOK	-3.89%
2020 FY	49.52 Million NOK	-22.74%
2020 Q4	2.91 Million NOK	-83.51%
2020 Q3	17.66 Million NOK	23.59%
2020 Q2	14.29 Million NOK	-2.38%
2020 Q1	14.64 Million NOK	18.15%
2019 Q1	18.32 Million NOK	40.66%
2019 FY	64.1 Million NOK	4.11%
2019 Q4	12.39 Million NOK	-30.08%
2019 Q3	17.72 Million NOK	13.21%
2019 Q2	15.65 Million NOK	-14.56%
2018 FY	61.57 Million NOK	-11.63%
2018 Q1	17.91 Million NOK	23.81%
2018 Q4	13.02 Million NOK	-20.14%
2018 Q3	16.31 Million NOK	13.95%
2018 Q2	14.31 Million NOK	-20.06%
2017 Q3	18.14 Million NOK	-0.84%
2017 Q2	18.3 Million NOK	6.49%
2017 Q1	17.18 Million NOK	-6.75%
2017 FY	69.67 Million NOK	6.55%
2017 Q4	14.46 Million NOK	-20.29%
2016 Q4	18.43 Million NOK	6.78%
2016 Q3	17.26 Million NOK	36.6%
2016 Q1	17.06 Million NOK	-2.14%
2016 Q2	12.63 Million NOK	-25.96%
2016 FY	65.39 Million NOK	17.69%
2015 Q2	10.69 Million NOK	-18.08%
2015 FY	55.56 Million NOK	19.71%
2015 Q4	17.43 Million NOK	21.22%
2015 Q1	13.05 Million NOK	0.18%
2015 Q3	14.38 Million NOK	34.56%
2014 Q4	13.02 Million NOK	6.31%
2014 FY	46.41 Million NOK	6.03%
2014 Q3	12.25 Million NOK	21.75%
2014 Q2	10.06 Million NOK	-9.08%
2014 Q1	11.07 Million NOK	-9.15%
2013 Q3	10.66 Million NOK	19.52%
2013 Q4	12.18 Million NOK	14.23%
2013 FY	43.77 Million NOK	-0.96%
2013 Q1	12 Million NOK	-6.15%
2013 Q2	8.92 Million NOK	-25.63%
2012 Q1	11.23 Million NOK	12.83%
2012 Q4	12.78 Million NOK	22.13%
2012 Q3	10.47 Million NOK	5.4%
2012 FY	44.2 Million NOK	4.37%
2012 Q2	9.93 Million NOK	-11.56%
2011 Q4	9.95 Million NOK	-5.18%
2011 Q1	11.49 Million NOK	-3.46%
2011 Q2	10.39 Million NOK	-9.59%
2011 Q3	10.49 Million NOK	0.99%
2011 FY	42.34 Million NOK	-20.84%
2010 Q4	11.91 Million NOK	14.65%
2010 Q2	12.55 Million NOK	-32.6%
2010 Q1	18.62 Million NOK	0.0%
2010 Q3	10.38 Million NOK	-17.23%
2010 FY	53.5 Million NOK	-50.23%
2009 FY	107.49 Million NOK	-22.19%
2008 FY	138.15 Million NOK	0.0%
2007 FY	- NOK	-100.0%
2006 FY	58.09 Million NOK	0.0%
2005 FY	- NOK	-100.0%
2004 FY	134.04 Million NOK	0.0%
2003 FY	- NOK	0.0%
2002 FY	- NOK	0.0%

Peer Operating Expenses Comparison of ArcticZymes Technologies ASA

Name	Operating Expenses	Operating Expenses Difference
Arctic Bioscience AS	-5730.00 NOK	1697604.363%
Aqua Bio Technology ASA	18.46 Million NOK	-426.762%
BerGenBio ASA	192.17 Million NOK	49.386%
Hofseth BioCare ASA	156.04 Million NOK	37.667%
PCI Biotech Holding ASA	25.23 Million NOK	-285.506%
Thor Medical ASA	7.16 Million NOK	-1258.288%
Ultimovacs ASA	215.73 Million NOK	54.914%

Global Stocks Search

ArcticZymes Technologies ASA (AZT.OL)

Operating Expenses Summary of ArcticZymes Technologies ASA

Annual Operating Expenses Chart of ArcticZymes Technologies ASA (2023 - 2002)

Historical Annual Operating Expenses of ArcticZymes Technologies ASA (2023 - 2002)

Peer Operating Expenses Comparison of ArcticZymes Technologies ASA